MSB 6.00% 94.0¢ mesoblast limited

things I've learnt over the last 14 months, page-26

  1. 894 Posts.
    lightbulb Created with Sketch. 2995
    Still no reply. I'm also not sure which type of stem cells the poster is discussing. I've been trying to work out if doubters are sceptical of the whole area of stem cell science or if they think MSB's lines are ineffective. I think it's the former. I know you can ignore a post but he got a lot of TUs and I think it represents a common view.

    Just to refer to that recent study in the JACC comparing auto- with allo- MSCs in NIDCM, which the authors say, accounts for half of all transplants. True, it was a small study but the authors said: "Clinical benefits of the magnitude shown here support the development of allo-hMSCs for treating NIDCM." They say a picture paints thousand words. I keep looking at that image of the heart they provided and thinking 'wow'.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.0¢
Change
-0.060(6.00%)
Mkt cap ! $1.073B
Open High Low Value Volume
99.0¢ 99.5¢ 93.5¢ $5.643M 5.894M

Buyers (Bids)

No. Vol. Price($)
14 72266 93.5¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 20000 1
View Market Depth
Last trade - 16.10pm 02/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.